According to I-Mab Biopharma's latest financial reports the company's current revenue (TTM ) is C$5.1 Million. In 2023 the company made a revenue of C$0.78 Million an increase over the revenue in the year 2022 that were of -C$6.63 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.